Quince Therapeutics, Inc (QNCX) insider trading
Every open-market stock purchase and sale by Quince Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $174K over the last 12 months (1 sale). No open-market buys.
- Last insider buy: Dirk Thye (CEO), $53.9K, 2 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $174K (1 sale). Last close $1.00 on Jun 7, 2026.
Recent QNCX insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 11, 2026 | Christopher J. Senner (Insider) | Bought (not open market) | — |
| Jun 11, 2026 | David Lamond (Insider) | Bought (not open market) | — |
| May 18, 2026 | Brigette Roberts (Officer) | Bought (not open market) | $5.7M |
| May 18, 2026 | Brigette Roberts (Officer) | Bought (not open market) | $186K |
| May 18, 2026 | Brigette Roberts (Officer) | Bought (not open market) | $32.6K |
| May 18, 2026 | Brigette Roberts (Officer) | Bought (not open market) | $20.6K |
| May 18, 2026 | Brigette Roberts (Officer) | Bought (not open market) | $12K |
| May 18, 2026 | Brigette Roberts (Officer) | Bought (not open market) | $11.2K |
| May 18, 2026 | Brigette Roberts (Officer) | Bought (not open market) | $6.2K |
| May 18, 2026 | Brigette Roberts (Officer) | Bought (not open market) | $3.1K |
| Jan 23, 2026 | Brendan Hannah (COO) | Sold (not open market) | — |
| Jan 23, 2026 | Dirk Thye (CEO) | Bought (not open market) | — |
| Jan 23, 2026 | Charles S. Ryan (President) | Bought (not open market) | — |
| Jan 2, 2026 | Margaret McLoughlin (Insider) | Bought (not open market) | — |
| Jan 2, 2026 | Christopher J. Senner (Insider) | Bought (not open market) | — |
| Jan 2, 2026 | David Lamond (Insider) | Bought (not open market) | — |
| Jan 2, 2026 | June Bray (Insider) | Bought (not open market) | — |
| Dec 26, 2025 | Luca Benatti (Insider) | Sold | $174K |
| Dec 10, 2025 | Dirk Thye (CEO) | Bought (not open market) | — |
| Dec 5, 2025 | Brendan Hannah (COO) | Bought (not open market) | — |
| Dec 5, 2025 | Brendan Hannah (COO) | Bought (not open market) | — |
Who's trading QNCX
- David Lamond, Director: other filings, last Jun 11, 2026
- Christopher J. Senner, Insider: other filings, last Jun 11, 2026
- Brigette Roberts, Officer: other filings, last May 18, 2026
- Dirk Thye, CEO: other filings, last Jan 23, 2026
- Brendan Hannah, COO: other filings, last Jan 23, 2026
- Charles S. Ryan, President: other filings, last Jan 23, 2026
- Margaret McLoughlin, Insider: other filings, last Jan 2, 2026
- June Bray, Insider: other filings, last Jan 2, 2026
- Luca Benatti, Insider: sold $174K (1 sale), last Dec 26, 2025
Get free alerts when an insider at Quince Therapeutics, Inc files a new trade →